These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Varani J; DaSilva M; Warner RL; Deming MO; Barron AG; Johnson KJ; Swartz RD Invest Radiol; 2009 Feb; 44(2):74-81. PubMed ID: 19077912 [TBL] [Abstract][Full Text] [Related]
45. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. Abujudeh HH; Kaewlai R; Kagan A; Chibnik LB; Nazarian RM; High WA; Kay J Radiology; 2009 Oct; 253(1):81-9. PubMed ID: 19709997 [TBL] [Abstract][Full Text] [Related]
46. Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital. Zou Z; Ma L; Li H J Magn Reson Imaging; 2009 Dec; 30(6):1309-12. PubMed ID: 19937931 [TBL] [Abstract][Full Text] [Related]
47. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide. Steger-Hartmann T; Raschke M; Riefke B; Pietsch H; Sieber MA; Walter J Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226 [TBL] [Abstract][Full Text] [Related]
48. Pathomechanisms of nephrogenic systemic fibrosis: new insights. Gupta A; Shamseddin MK; Khaira A Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732 [TBL] [Abstract][Full Text] [Related]
49. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities. Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233 [TBL] [Abstract][Full Text] [Related]
53. [Nephrogenic systemic fibrosis--new clinical entity]. Prvulović M Med Pregl; 2008; 61(9-10):439-41. PubMed ID: 19203058 [TBL] [Abstract][Full Text] [Related]
54. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Edward M; Quinn JA; Burden AD; Newton BB; Jardine AG Radiology; 2010 Sep; 256(3):735-43. PubMed ID: 20663970 [TBL] [Abstract][Full Text] [Related]
55. No Cases of Nephrogenic Systemic Fibrosis after Administration of Gadoxetic Acid. Starekova J; Bruce RJ; Sadowski EA; Reeder SB Radiology; 2020 Dec; 297(3):556-562. PubMed ID: 32990511 [TBL] [Abstract][Full Text] [Related]
57. Trypsin potentiates human fibrocyte differentiation. White MJ; Glenn M; Gomer RH PLoS One; 2013; 8(8):e70795. PubMed ID: 23951012 [TBL] [Abstract][Full Text] [Related]
58. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions. Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497 [TBL] [Abstract][Full Text] [Related]
59. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation. Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755 [TBL] [Abstract][Full Text] [Related]